Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by LithLoveron May 17, 2023 11:17am
150 Views
Post# 35452484

Upcoming AGM

Upcoming AGMI think it's time for a new board.  Other than Riggs who has stepped up with his financing I don't see much headway being made.  Tripp doesn't seem to be able to sell or market his way out of a wet paper bag.

I will vote for GEM to get the 25% as it would be in their best ineterest to help raise the share price and/or find a buyer.  Same with the 10% insider.  Much better for Riggs or an insider to own shares.

As for the other directors including Tripp they don't get my vote.  I see little in the way of execution or results, time for a change of the board and likely a change in CEO.  This board and CEO are not sales or marketing focused.  Significant changes are needed.   
<< Previous
Bullboard Posts
Next >>